Background: Associations between cognition and brain markers of amyloid, tau, and neurodegeneration are poorly understood in the oldest-old (>90 years) compared to younger populations. Prior work suggests that the link between neuropathology and cognition may become weaker in advanced old age, reducing the applicability of accepted biomarker cascade models of Alzheimer's disease progression. Addressing this question in the oldest-old is challenging, partly due to limited data and methodological challenges of neuroimaging analysis. In this study, we examine the associations of (1) cerebral amyloid and tau, (2) amyloid and cognitive performance, and (3) tau and cognitive performance, in the overall group and as stratified by amyloid positivity.
Method: Participants were from the oldest-old cohort from the 90+ Study at University of California, Irvine (N=98; mean age at assessment=92.04 years; %female=53,). We used MRI-free analyses of PET imaging to investigate the relations among amyloid (AV45), tau (AV1451) in Braak regions 1/2, 3/4 and 5/6, and cognitive measure (Mini-Mental State Exam [MMSE]). Native PET images were warped directly to an appropriate PET template, yielding SUVRs computed using cerebellar reference means. Amyloid positivity used an SUVR cutoff of 1.11, computed over a standard index region. All regressions were controlled for age, sex, education, and Apolipoprotein E status.
Result: Group characteristics are in Table 1. In the amyloid positive group (N=61), we found significant associations for amyloid with tau in Braak 1/2 (p=0.03; Figure 1), and MMSE (p=0.045; Figure 2). Associations of MMSE with tau Braak regions varied (Braak 1/2: p=0.086, Braak 3/4: p=0.018, Braak 5/6: p=0.061; Figure 3). We observed no significant associations in the full cohort or in the amyloid negative group.
Conclusion: MRI-free PET processing yielded results in the oldest-old that are consistent with expected relations among amyloid, tau and cognition. Accurate SUVR measurement requires rigorous template registration and quality control. All significant associations occurred in the amyloid positive group, showing expected relations of amyloid to cognition and early Braak stage tau, and tau to cognition, consistent with accepted models. However, small sample size limited our findings. Further studies are needed to clarify the applicability of amyloid-tau models in this age group.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.093059 | DOI Listing |
J Neurosci
January 2025
German Center for Neurodegenerative Diseases (DZNE), Magdeburg 39120, Germany
The precuneus is a site of early amyloid-beta (Aβ) accumulation. Previous cross-sectional studies reported increased precuneus fMRI activity in older adults with mild cognitive deficits or elevated Aβ. However, longitudinal studies in early Alzheimer's disease (AD) are lacking and the relationship to the Apolipoprotein-E () genotype is unclear.
View Article and Find Full Text PDFAgeing Res Rev
January 2025
Department of Pharmaceutics, NIMS Institute of Pharmacy, NIMS University, Jaipur 303121, Rajasthan, India.
Neurodegenerative diseases (NDs) are debilitating disorders characterized by the progressive and selective loss of function or structure in the brain and spinal cord. Both chronic and acute forms of these diseases are associated with significant morbidity and mortality, as they involve the degeneration of neurons in various brain regions. Misfolding and aggregation of amyloid proteins into oligomer and β-sheet rich fibrils share as common hallmark and lead to neurotoxicity.
View Article and Find Full Text PDFBrain Res Bull
January 2025
Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China.
Alzheimer's disease (AD) stands as one of the most prevalent neurodegenerative disorders, characterized by a progressive decline in cognitive function, neuroinflammation, amyloid-beta (Aβ) plaques, and neurofibrillary tangles (NFTs). With the global aging population, the incidence of AD continues to rise, yet current therapeutic strategies remain limited in their ability to significantly alleviate cognitive impairments. Therefore, a deeper understanding of the molecular mechanisms underlying AD is imperative for the development of more effective treatments.
View Article and Find Full Text PDFNeurology
January 2025
Leonard Davis School of Gerontology, University of Southern California, Los Angeles.
Background And Objectives: Cerebrovascular reactivity (CVR) represents the ability of cerebral blood vessels to regulate blood flow in response to vasoactive stimuli and is related to cognition in cerebrovascular and neurodegenerative conditions. However, few studies have examined CVR in the medial temporal lobe, known to be affected early in Alzheimer disease and to influence memory function. We aimed to examine whether medial temporal CVR is associated with memory function in older adults with and without mild cognitive impairment (MCI).
View Article and Find Full Text PDFPLoS One
January 2025
Washington University School of Medicine, NeuroGenomics and Informatics Center, St. Louis, MO, United States of America.
Case-only designs in longitudinal cohorts are a valuable resource for identifying disease-relevant genes, pathways, and novel targets influencing disease progression. This is particularly relevant in Alzheimer's disease (AD), where longitudinal cohorts measure disease "progression," defined by rate of cognitive decline. Few of the identified drug targets for AD have been clinically tractable, and phenotypic heterogeneity is an obstacle to both clinical research and basic science.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!